PHARMACEUTICAL PREPARATIONS IMPROVEMENT

Brand Owner (click to sort) Address Description
BIFELAN Mitsubishi Kasei Corporation 5-2, Marunouchi 2-chome Chiyoda-ku, Tokyo 100 Japan pharmaceutical preparations for the improvement or treatment of mental symptoms cause by organic disorders of the brain resulting from pathological or abnormal conditions or diseases, injuries, or surgery;
GINCOSAN Pharmaton S.A. Via Mulini Bioggio CH-6934 Switzerland pharmaceutical preparations for the improvement of peripheric blood circulation; dietary supplements;
MEE-HU-MEDICUS Fond Livsdraben ESPEVEJ 2 HARLEV J. 8462 Denmark Pharmaceutical preparations for the improvement of the immune system and the support of the effectiveness of antibiotics; Veterinary preparations for the improvement of the immune system and the support of the effectiveness of antibiotics; Sanitary preparations for the improvement of the immune system and the support of the effectiveness of antibiotics; Dietetic substances, namely, glutamine, glycine, alanine, valine, serine, leucine, isoleucine, tryptophan, proline, lysine, arginine, asparagine, and ribose, adapted for medical use for the improvement of the immune system and support of the effectiveness of antibiotics;
MEE-HU-MEDICUS Marianne Brøndlund Espevej 2 DK-8462 Harlev Denmark Pharmaceutical preparations for the improvement of the immune system and the support of the effectiveness of antibiotics; Veterinary preparations for the improvement of the immune system and the support of the effectiveness of antibiotics; Sanitary preparations for the improvement of the immune system and the support of the effectiveness of antibiotics; Dietetic substances, namely, glutamine, glycine, alanine, valine, serine, leucine, isoleucine, tryptophan, proline, lysine, arginine, asparagine, and ribose, adapted for medical use for the improvement of the immune system and support of the effectiveness of antibiotics;
MEMFOR Pharmaton S.A. Via Mulini Bioggio CH-6934 Switzerland pharmaceutical preparations for the improvement of mental capacity; dietary supplements;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.